Contribution of Neuroepigenetics to Huntington's Disease.
about
The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin.Transcriptional Dysregulation and Post-translational Modifications in Polyglutamine Diseases: From Pathogenesis to Potential Therapeutic Strategies.Early alteration of epigenetic-related transcription in Huntington's disease mouse models.Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activatorMinimotifs dysfunction is pervasive in neurodegenerative disorders
P2860
Contribution of Neuroepigenetics to Huntington's Disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Contribution of Neuroepigenetics to Huntington's Disease.
@en
Contribution of Neuroepigenetics to Huntington's Disease.
@nl
type
label
Contribution of Neuroepigenetics to Huntington's Disease.
@en
Contribution of Neuroepigenetics to Huntington's Disease.
@nl
prefLabel
Contribution of Neuroepigenetics to Huntington's Disease.
@en
Contribution of Neuroepigenetics to Huntington's Disease.
@nl
P2860
P50
P356
P1476
Contribution of Neuroepigenetics to Huntington's Disease
@en
P2093
Caroline Lotz
Emmanuel Brouillet
P2860
P356
10.3389/FNHUM.2017.00017
P577
2017-01-30T00:00:00Z